The legal dispute began in March 2023 when ABEC filed a lawsuit accusing GOOD Meat of breach of contract by failing to pay its bills on time.
One well-publicized side effect of GLP-1 drugs is a loss of lean muscle mass, prompting a surge of interest in drugs that can attenuate the problem, says ProFuse Technology.
With funding for cultivated meat almost drying up in 2024 and key players warning the sector could collapse without a huge influx of public money, where does it go from here?
Given the rapid growth of drones for spraying crops—a market dominated by Chinese supplier DJI—our coverage of lawmakers’ attempts to restrict DJI’s US activities featured heavily in our ‘most read’ list this year.
“A lot of foodtech founders in this dry capital environment are beating their heads against the wall with the conviction that the wall will break before their heads do,” observes Paul Shapiro at The Better Meat Co. “That said, deals are still getting done.”
While the concept of minimal viable product (MVP) has proven its value in software, it doesn’t translate so well into food Unlike software, a food product cannot be “patched” once it hits shelves…
It is “clearly communicated to all competitors in our documentations that awards are not guaranteed,” says XPRIZE. “This is not the first time a winner has not been identified by our judges.”
“Our new report provides proof that with the right technology there is a commercially viable path to market” for cultivated meat, claims SuperMeat CEO Ido Savir.
“We’re at the precipice of a mass startup extinction,” warn the founders of now-defunct cultivated meat firm SCiFi Foods. But you can plan for a “graceful exit.”
Antwerp-based FlyBlast has a stable black soldier fly breeding line that expresses human insulin “at very high yields,” claims CEO Johan Jacobs.
At Mosa Meat, says VP global public affairs Robert Jones, “We tightened our belts, we went back to the drawing board on the long-term strategic plan and got more focused.”
Existing single-cell suspension stir tank bioreactors “can’t be used to effectively produce non-GM, cultivated muscle and fat,” claims Mission Barns.
“Cultivated meat can address the issues that consumers care about and have already shown they will pay extra for, so if we can do it efficiently, why wouldn’t they buy it?” asks Jeff ‘Trip’ Tripician.
According to auctioneer Silicon Valley Disposition, equipment up for sale includes “high-end and late-model (mostly 2022) R&D instruments” including bioreactors.
“But one thing I will say,” says Dr. David Kaplan, “I don’t think stir tank reactors that have been used in pharma are going to work here. They’re just too expensive.”
UPSIDE Foods has engaged in a fresh round of layoffs in a bid to extend its runway as it expands its facility in Emeryville, California.
GWP100, the default timescale for determining carbon dioxide equivalence (CO2eq), is problematic when it comes to measuring methane emissions, says Aleph Farms.
Israeli startup Ever After Foods has just secured a $10m capital injection to scale patented tech it claims can slash capex and opex costs in the nascent—but already beleaguered—cultivated meat industry.
“Given challenges in the fundraising market, we’ve appointed an advisory firm to run a sale process,” said cofounder and CEO Joshua March.
Prolific Machines has developed a novel way to control cells used in biomanufacturing by deploying light instead of pricey growth factors and other signaling molecules.
